Ventana Medical Systems
Steven Stratton has worked as an Associate Professor at the University of Arizona from January 2000 to October 2015. Steven then joined Ventana Medical Systems, where they worked as a Clinical Science Leader from October 2015 to April 2017, and later as a Medical Affairs Director from May 2017 to the present (end date not specified).
Steven Stratton has a Doctor of Philosophy (PhD) in Pharmacology and Toxicology from the University of Arizona. Prior to that, they obtained a Bachelor of Arts (BA) in Chemistry from Gustavus Adolphus College.
This person is not in the org chart
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.